Single Dose Study of MK-6194 in Healthy Japanese Participants

Phase 1

• Conditions: lcerative colitis

• Registration Number: JPRN-jRCT2051210183
• Lead Sponsor: Tanaka Yoshiyuki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-02
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 48

Inclusion Criteria

Healthy Japanese male between the ages of 20 and 55 years with BMI within 18 to 25 kg/m2 inclusive and weight >=50 kg

Exclusion Criteria

History of clinically significant abnormalities or diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adverse events

Secondary Outcome Measures

Name	Time	Method
- AUC0-last, AUC0-inf, Cmax, Tmax, apparent t1/2, CL/F and Vz/F<br>- Immunophenotyping of regulatory T cells